Nucleophosmin 1 pseudogene 22 (NPM1P22)

Nucleophosmin 1 pseudogene 22 (NPM1P22) is a member of the nucleophosmin pseudogene family and is annotated as a pseudogene in major genomic databases. Pseudogenes are genomic DNA sequences similar to normal genes but are generally non-functional; they often arise by duplication or retrotransposition of protein-coding genes but lack regulatory elements or essential coding capacity. There is no evidence that NPM1P22 encodes a functional protein or serves a direct biological or therapeutic function. It is not considered a receptor, enzyme, transcription factor, or target of pharmacological intervention. No published studies link NPM1P22 to disease mechanisms, biomarker roles, or drug response, and it does not participate in any recognized molecular processes relevant to health or disease. NPM1P22 is a pseudogene related to nucleophosmin 1; it is not a therapeutic or biological target and has no clinical or pharmacological role. If a gene product or function is of interest, refer to related protein-coding genes such as nucleophosmin 1 (NPM1), which plays a well-characterized role in ribosome biogenesis, cell proliferation, and is relevant in diseases like acute myeloid leukemia. NPM1P22 itself serves only as a genomic annotation and not a gene of therapeutic interest.

Other names

NPM1P22nucleophosmin pseudogene 22